PortfoliosLab logo

Novo Nordisk A/S

NVO
Equity · Currency in USD
Sector
Healthcare
Industry
Biotechnology
ISIN
US6701002056
CUSIP
670100205

NVOPrice Chart


Chart placeholderClick Calculate to get results
S&P 500

NVOPerformance

The chart shows the growth of $10,000 invested in Novo Nordisk A/S on Jan 5, 2010 and compares it to the S&P 500 index or another benchmark. It would be worth nearly $94,847 for a total return of roughly 848.47%. All prices are adjusted for splits and dividends.


NVO (Novo Nordisk A/S)
Benchmark (S&P 500)

NVOReturns in periods

Returns over 1 year are annualized

PeriodReturn
1M-2.95%
6M42.84%
YTD43.63%
1Y46.08%
5Y21.84%
10Y19.74%

NVOMonthly Returns Heatmap


Chart placeholderClick Calculate to get results

NVOSharpe Ratio Chart

The Sharpe ratio shows whether the portfolio's excess returns are due to smart investment decisions or a result of taking a higher risk. The higher a portfolio's Sharpe ratio, the better its risk-adjusted performance.

The current Novo Nordisk A/S Sharpe ratio is 1.73. A Sharpe ratio greater than 1.0 is considered acceptable.

The chart below displays rolling 12-month Sharpe Ratio.


NVO (Novo Nordisk A/S)
Benchmark (S&P 500)

NVODividends

Novo Nordisk A/S granted a 1.53% dividend yield in the last twelve months, as of Oct 9, 2021. The annual payout for that period amounted to $1.51 per share.


PeriodTTM20202019201820172016201520142013201220112010
Dividend$1.51$0.52$1.24$1.14$1.14$1.41$0.76$0.83$0.64$0.50$0.36$0.28

Dividend yield

1.53%0.74%2.14%2.47%2.12%3.93%1.31%1.96%1.72%1.53%1.58%1.25%

NVODrawdowns Chart

The Drawdowns chart displays portfolio losses from any high point along the way.


NVO (Novo Nordisk A/S)
Benchmark (S&P 500)

NVOWorst Drawdowns

The table below shows the maximum drawdowns of the Novo Nordisk A/S. A maximum drawdown is an indicator of risk. It shows a reduction in portfolio value from its maximum due to a series of losing trades.

The maximum drawdown since January 2010 for the Novo Nordisk A/S is 46.15%, recorded on Nov 23, 2016. It took 289 trading sessions for the portfolio to recover.


Depth

Start

To Bottom

Bottom

To Recover

End

Total

-46.15%Aug 4, 2015332Nov 23, 2016289Jan 19, 2018621
-28.04%Apr 25, 2011117Oct 7, 201183Feb 7, 2012200
-26.85%Jan 29, 2018179Oct 11, 2018264Oct 30, 2019443
-23.65%Mar 5, 202012Mar 20, 202024Apr 24, 202036
-21.01%Feb 7, 201395Jun 24, 2013138Jan 9, 2014233
-14.66%Oct 23, 20129Nov 6, 201244Jan 10, 201353
-14.54%Sep 19, 201475Jan 6, 201549Mar 18, 2015124
-13.91%Apr 23, 201230Jun 4, 201238Jul 27, 201268
-13.22%Oct 13, 202014Oct 30, 202034Dec 18, 202048
-11.82%May 4, 201015May 24, 201018Jun 18, 201033

NVOVolatility Chart

Current Novo Nordisk A/S volatility is 25.62%. The chart below shows the rolling 10-day volatility. Volatility is a statistical measure showing how big price swings are in either direction. The higher asset volatility, the riskier it is, because the price movements are less predictable.


NVO (Novo Nordisk A/S)
Benchmark (S&P 500)

Portfolios with Novo Nordisk A/S


Loading data...

More Tools for Novo Nordisk A/S